LATEST NEWS

High school interns dive into the worlds of microscopy and histopathology
COVID-19 boosters may lead to a stable antibody and T cell population in years to come
New measles, Nipah research offers a window into viral assembly
New study shows how new therapies might target Lassa and Ebola viruses
LJI scientists, in collaboration with researchers from the Institut Pasteur in France, capture new high-resolution view of rabies virus, revealing potential vaccine targets
How softball brings LJI scientists and admin staff together
Holmes has led the charge in intellectual property and regulatory compliance at two renowned biomedical centers
IP Generator, Inc., (“IPG”) and La Jolla Institute for Immunology (“LJI”), based in La Jolla, California, USA, have entered into a Master Collaborative Research and Development Agreement (“this agreement”) dated May 12, 2022.
New investigation reveals the strength of T cell, B cell, and antibody responses over time
LJI research reveals how aggressive T cells can make heart disease even worse
LJI's Lindy Edwards on her double life as a jazz band leader